Oxford pauses COVID-19 vaccine study in kids, awaits more data on blood clot issues

  • 📰 Reuters
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Education Education Headlines News

Education Education Latest News,Education Education Headlines

The University of Oxford said on Tuesday it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits for more data on rare blood clotting issues in adults who received the shot.

The trial disruption is the latest blow to the vaccine, once hailed as a milestone in the fight against the pandemic, after several countries restricted its use in light of reports of medical issues after inoculations.

The university said in February it planned to enroll 300 volunteers aged 6-17 years, based in the United Kingdom, as part of this study. A senior EMA official has said there is a clear association between the vaccine and CVST, though the direct cause of the clots is still unknown. Spats with governments across Europe about production, supplies, possible side effects and the vaccine’s merits have dogged the Anglo-Swedish drugmaker for months.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Guys I Need All Of Yours Help To Get 1K Subscribers.Please Support Me 👇👇👇👇👇👇👇

What should people do if they are sick due to vaccine problems?

AstraZeneca/Oxford

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in EDUCATİON

Education Education Latest News, Education Education Headlines